Blueprint Medicines

Acquired by Sanofi / NASDAQ: BPMC
Precision therapy company striving to improve human health.
Precision therapy company striving to improve human health.

Investment Team

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, MA

Initial Investment

2012
Blueprint Medicines

Blueprint Medicines (NASDAQ: BPMC) is a precision therapy company striving to improve human health. Blueprint Medicines was acquired by Sanofi in 2025.